SCHEMBL4904684

SCHEMBL4904684

COC(=O)c1cc(S(=O)(=O)NCCSc2ccc(Oc3ccc(F)c(C)c3)cc2)cc(C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.43
TSHR P16473 6/20 0.43
LMNA P02545 7/20 0.42
HTT P42858 3/20 0.42
MAPT P10636 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
NFKB1 P19838 1/20 0.38
PMP22 Q01453 1/20 0.38
HIF1A Q16665 1/20 0.38
GAA P10253 2/20 0.38
PKM P14618 2/20 0.36
MAPK1 P28482 2/20 0.36
TP53 P04637 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MTNR1A P48039 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905762 0.92 ALDH1A1 (0.43) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4902542 0.92 ALDH1A1 (0.43) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4902594 0.92 ALDH1A1 (0.44) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4905593 0.92 ALDH1A1 (0.53) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4895337 0.91 ALDH1A1 (0.48) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4902978 0.90 ALDH1A1 (0.53) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4904193 0.90 ALDH1A1 (0.47) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4902415 0.89 ALDH1A1 (0.44) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4899776 0.89 ALDH1A1 (0.43) ALDH1A1TSHRLMNAHTTMAPT
SCHEMBL4906198 0.88 ALDH1A1 (0.46) ALDH1A1TSHRLMNAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885LMNA 317/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.